Norris Medicines share news and announcements
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹15.00.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 748
Norris Medicines share news and announcements
394 announcements, routine notices left out, newest first. Page 2 of 8.
Feb 2025
13 Feb · Results
13 Feb · Results
10 Feb · Board meeting
Meeting on 13 Feb 2025: quarterly results
Dec 2024
24 Dec · Revised Certificate Under Reg 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2024.
23 Dec · Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 For Receipt Of Request Letter From Promoter Of The Company For Reclassification From Promoter & Promoter Group To Public Category.
Nov 2024
14 Nov · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended 30.09.2024.
14 Nov · Adoption Of Financials In Board Meeting Held On Thursday, 14Th November, 2024 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
14 Nov · Board meeting
11 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
1 Oct · Meeting
1 Oct · Meeting
Sep 2024
30 Sep · Meeting
30 Sep · Intimation Of Change In Board Of Directors Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
25 Sep · Board meeting
Meeting on 25 Sep 202425 Sep · Management
25 Sep · Board meeting
15 Sep · Meeting
6 Sep · Meeting
Aug 2024
24 Aug · Management
14 Aug · Board meeting
9 Aug · Board meeting
Meeting on 14 Aug 2024: annual general meeting and quarterly results
Jul 2024
Jun 2024
29 Jun · Management
May 2024
22 May · Board meeting
Meeting on 29 May 2024: audited results and quarterly results
Apr 2024
29 Apr · Board meeting
Meeting on 29 Apr 202429 Apr · Board meeting
27 Apr · Compliance Certificate As Per Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024.
24 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mar 2024
29 Mar · Board meeting
22 Mar · Board meeting
Feb 2024
8 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Jan 2024
Dec 2023
29 Dec · Board meeting
22 Dec · Board meeting
Meeting on 29 Dec 2023